Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults
1 other identifier
interventional
52
1 country
2
Brief Summary
Creatine supplementation improves measures of muscle accretion and performance compared to placebo during a resistance training program. However, the optimal creatine supplementation protocol for maximizing these improvements is unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2024
CompletedFirst Submitted
Initial submission to the registry
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedJune 3, 2024
May 1, 2024
8 months
May 16, 2024
May 29, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Body Composition
Whole-body lean mass (kg) using bioelectrical impedance analysis
baseline, week 16
Muscle Hypertrophy
Muscle thickness of the biceps, triceps, quadriceps, hamstrings and calf muscle using B-mode ultrasound (cm)
baseline, week 16
Strength
1-repetition maximum leg press and chest press (kg)
baseline, week 16
Endurance
Repetitions to fatigue for leg press and chest press (total number)
baseline, week 16
Power
Medicine ball throw (cm)
baseline, week 16
Hydration
Total body water (kg) using bioelectrical impedance analysis
baseline, week 16
Power
Vertical jump (watts)
baseline, weekn 16
Study Arms (4)
Creatine Before Training
EXPERIMENTAL5 grams of creatine monohydrate + 3 grams of placebo immediately before training sessions; 8 grams of placebo immediately after training sessions; 8 grams of placebo on non-training days.
Creatine After Training
EXPERIMENTAL5 grams of creatine monohydrate + 3 grams of placebo immediately after training sessions; 8 grams of placebo immediately before training sessions; 8 grams of placebo on non-training days.
Creatine Non-Training
EXPERIMENTAL5 grams of creatine monohydrate + 3 grams of placebo on non-training days; 8 grams of placebo immediately before training sessions; 8 grams of placebo immediately after training sessions.
Placebo
PLACEBO COMPARATOR8 grams of placebo immediately before training sessions; 8 grams of placebo immediately after training sessions; 8 grams of placebo on non-training days
Interventions
Corn-Starch Maltodextrin
Creatine
Eligibility Criteria
You may qualify if:
- Physically active (performing structured resistance training \> 2x/week for ≥ 4 weeks)
- Males and females (age 18-39)
You may not qualify if:
- Pregnant or nursing
- Have consumed creatine monohydrate within 30 days prior to the start of the study
- Pre-existing allergies to the placebo
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Regina
Regina, Saskatchewan, S4S4H4, Canada
University of Regina
Regina, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Darren Candow
University of Regina
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- blinding
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 16, 2024
First Posted
June 3, 2024
Study Start
May 15, 2024
Primary Completion
December 30, 2024
Study Completion
August 30, 2025
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share